Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Other Operating Expenses (2022 - 2025)

Historic Other Operating Expenses for Catheter Precision (VTAK) over the last 4 years, with Q2 2025 value amounting to $1.8 million.

  • Catheter Precision's Other Operating Expenses rose 22295.41% to $1.8 million in Q2 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 10248.41%. This contributed to the annual value of -$70.7 million for FY2023, which is 7022.07% down from last year.
  • Catheter Precision's Other Operating Expenses amounted to $1.8 million in Q2 2025, which was up 22295.41% from $119000.0 recorded in Q1 2025.
  • In the past 5 years, Catheter Precision's Other Operating Expenses registered a high of $4.7 million during Q2 2023, and its lowest value of -$76.4 million during Q4 2023.
  • For the 4-year period, Catheter Precision's Other Operating Expenses averaged around -$5.6 million, with its median value being $111000.0 (2022).
  • Per our database at Business Quant, Catheter Precision's Other Operating Expenses plummeted by 7423689.32% in 2023 and then surged by 30169.49% in 2025.
  • Quarter analysis of 4 years shows Catheter Precision's Other Operating Expenses stood at $103000.0 in 2022, then plummeted by 74236.89% to -$76.4 million in 2023, then skyrocketed by 98.35% to -$1.3 million in 2024, then skyrocketed by 246.55% to $1.8 million in 2025.
  • Its Other Operating Expenses stands at $1.8 million for Q2 2025, versus $119000.0 for Q1 2025 and -$1.3 million for Q3 2024.